Please use this identifier to cite or link to this item:
Title: Investigating the “real-world” clinical impact of treatment sequencing in advanced pancreatic cancer outcomes: a PURPLE translational registry analysis.
Authors: Wong, Rachel
Ananda, Sumitra
Other Authors: Santucci, Jordan
Lee, Belinda
Tomson, Ben
Michael, Michael
Shapiro, Julia
Clarke, Kate
Pattison, Sharon
Burge, Matthew
Zielinski, Rob
Nikfarjam, Mehrdad
Lipton, Lara
Gibbs, Peter
Keywords: Advanced Pancreatic Cancer
Pancreatic Ductal Adenocarcinoma
Gemcitabine Monotherapy
Palliative Chemotherapy
Survival Outcomes
PURPLE registry
(Pancreatic cancer – Understanding Routine Practice and Lifting End results
Chisquare Test
Mann-Whitney U Test
Kaplan-Meier Method
Breslow Test
Cox Proportional Hazards Regression
Cancer Services Clinical Institute, Epworth HealthCare, Victoria, Australia
Issue Date: Oct-2020
Conference Name: Epworth HealthCare Research Month 2020
Conference Location: Epworth Research Institute, Victoria, Australia
Abstract: To assess whether first-then-second-line treatment sequence wither either FOLFIRINOX or Gem/Nab-P as first-line palliative chemotherapy impacts survival outcomes.
Type: Conference Poster
Affiliated Organisations: Walter & Eliza Hall Institute (WEHI), Vic, Australia
The Royal Melbourne Hospital, Vic, Australia
University of Melbourne, Australia
Peter MacCallum Cancer Centre, Vic, Australia
Northern Health, Vic, Australia
Cabrini Health, Vic, Australia
Eastern Health, VIC, Australia
Wellington Hospital, New Zealand
Dunedin University Hospital, New Zealand
Royal Brisbane and Women’s Hospital, Qld, Australia
Orange and Dubbo Base Hospitals, NSW, Australia
Austin Health, Melbourne, Australia
Western Health, Melbourne, Australia
Type of Clinical Study or Trial: Retrospective studies
Appears in Collections:Research Week

Files in This Item:
File Description SizeFormat  
Santucci. Jordan_Epworth Research Month 2020 Poster.pdf3.5 MBAdobe PDFThumbnail

Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.